Acne Medication Market Size

Acne Medication Market size is estimated at USD 12.1 billion in 2024 and is set to exceed USD 23.3 billion by the end of 2037, expanding at over 5.4% CAGR during the forecast period i.e., between 2025-2037. In 2025, the industry size of acne medication is assessed at USD 12.7 billion.

The rising prevalence of acne or skin disorders such as acne, eczema, and psoriasis is the prime reason fuelling the acne medication market. A 2023 report published by the World Health Organization (WHO) stated that skin conditions are estimated to impact 1.8 billion people at any point in time.

Antibiotics, retinoids, and isotretinoin are some medications used for acne treatment, wherein antibiotics are the most used drugs for acne treatment and are expected to exhibit high global demand throughout the forecast period. According to a report by the National Center for Biotechnology Information (NCBI) published in June 2023, the prevalence of acne among teenagers worldwide is around 80%. The same source also estimates that adult acne problem affects 40% of the population.

Additionally, companies are launching new formulations that combine existing ingredients with advanced delivery systems are also driving the acne medication market. For instance, in July 2024, Crown Laboratories announced that its brand PanOxyl has come with the latest innovations in acne-banishing body spray. Body sprays formulated with 2% salicylic acid are now aiding in clearing blemishes and unclogging pores more effectively, leading to long-lasting results.